Patent · US Active

Pleuromutilin derivatives for the treatment of diseases mediated by microbes

US8071643B2 · kind B2 · utility

2Cited by

0References

11Claims

0Family size

Assignee

NABRIVA THERAPEUTICS GMBH · AT

Inventors

Rosemarie Mang · Wien, AT
Werner Heilmayer · Staprijk, AT
Rudolf Badegruber · Wien, AT
Dirk Strickmann · Wien, AT
Rodger Novak · Wien, AT
Mathias Ferencic · Wien, AT
Atchyuta Rama Chandra Murty Bulusu · Perchtoldsdorf, AT

Key dates

Filing date	Mar 19, 2008
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Jan 16, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/99
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pleuromutilin derivative compound of general formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.